![](/img/cover-not-exists.png)
Observations from a 14-week open-label trial with memantine suggest variable response on behavioral symptoms and cognition, depending on former treatment of AD
DAUTZENBERG, PAUL L. J., WOUTERS, CEES J., BOOTSMA, JANET E. M.Volume:
18
Journal:
International Psychogeriatrics
DOI:
10.1017/s104161020625347x
Date:
March, 2006
File:
PDF, 182 KB
2006